Literature DB >> 27193014

Anti-dormant mycobacterial activity and target molecule of melophlins, tetramic acid derivatives isolated from a marine sponge of Melophlus sp.

Masayoshi Arai1, Yoshi Yamano2, Kentaro Kamiya2, Andi Setiawan3, Motomasa Kobayashi4.   

Abstract

Tuberculosis (TB), caused by Mycobacterium tuberculosis infection, is a major world health problem that is responsible for the deaths of 1.5 million people each year. In addition, the requirement for long-term therapy to cure TB complicates treatment of the disease. One of the major reasons for the extended chemotherapeutic regimens and wide epidemicity of TB is that M. tuberculosis has the ability to persist in a dormant state. We therefore established a new screening system to search for substances with activity against dormant mycobacteria using M. smegmatis and M. bovis BCG cultivated in medium containing propionate as sole carbon source to induce dormancy. Subsequently, melophlins A (1), G (2), H (3), and I (4), tetramic acid derivatives, were re-discovered from the Indonesian marine sponge of Melophlus sp. as anti-dormant mycobacterial substances. Moreover, target analysis of melophlin A indicated that it targeted the BCG1083 protein of putative exopolyphosphatase and the BCG1321c protein of diadenosine 5',5‴-P(1),P(4)-tetraphosphate phosphorylase.

Entities:  

Keywords:  Antibiotic; Carbon source; Dormant; Marine sponge; Melophlin; Tuberculosis

Mesh:

Substances:

Year:  2016        PMID: 27193014     DOI: 10.1007/s11418-016-1005-1

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  26 in total

1.  The Ras pathway modulator melophlin A targets dynamins.

Authors:  Tanja Knoth; Karin Warburg; Catherine Katzka; Amrita Rai; Alexander Wolf; Andreas Brockmeyer; Petra Janning; Thomas F Reubold; Susanne Eschenburg; Dietmar J Manstein; Katja Hübel; Markus Kaiser; Herbert Waldmann
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

2.  An apaH mutation causes AppppA to accumulate and affects motility and catabolite repression in Escherichia coli.

Authors:  S B Farr; D N Arnosti; M J Chamberlin; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

3.  Oxygen depletion-induced dormancy in Mycobacterium bovis BCG.

Authors:  A Lim; M Eleuterio; B Hutter; B Murugasu-Oei; T Dick
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

4.  Neamphamide B, new cyclic depsipeptide, as an anti-dormant mycobacterial substance from a Japanese marine sponge of Neamphius sp.

Authors:  Yoshi Yamano; Masayoshi Arai; Motomasa Kobayashi
Journal:  Bioorg Med Chem Lett       Date:  2012-05-24       Impact factor: 2.823

5.  Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.

Authors:  J D McKinney; K Höner zu Bentrup; E J Muñoz-Elías; A Miczak; B Chen; W T Chan; D Swenson; J C Sacchettini; W R Jacobs; D G Russell
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

6.  Genetic requirements for mycobacterial survival during infection.

Authors:  Christopher M Sassetti; Eric J Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

7.  Regulation of dinucleoside polyphosphate pools by the YgdP and ApaH hydrolases is essential for the ability of Salmonella enterica serovar typhimurium to invade cultured mammalian cells.

Authors:  Thamir M Ismail; C Anthony Hart; Alexander G McLennan
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

8.  Halicyclamine A, a marine spongean alkaloid as a lead for anti-tuberculosis agent.

Authors:  Masayoshi Arai; Mari Sobou; Catherine Vilchéze; Anthony Baughn; Hiroyuki Hashizume; Patamaporn Pruksakorn; Shunsuke Ishida; Makoto Matsumoto; William R Jacobs; Motomasa Kobayashi
Journal:  Bioorg Med Chem       Date:  2008-06-13       Impact factor: 3.641

9.  Identification of the target protein of agelasine D, a marine sponge diterpene alkaloid, as an anti-dormant mycobacterial substance.

Authors:  Masayoshi Arai; Yoshi Yamano; Andi Setiawan; Motomasa Kobayashi
Journal:  Chembiochem       Date:  2013-11-14       Impact factor: 3.164

10.  Deficiency of the novel exopolyphosphatase Rv1026/PPX2 leads to metabolic downshift and altered cell wall permeability in Mycobacterium tuberculosis.

Authors:  Yu-Min Chuang; Nirmalya Bandyopadhyay; Dalin Rifat; Harvey Rubin; Joel S Bader; Petros C Karakousis
Journal:  MBio       Date:  2015-03-17       Impact factor: 7.867

View more
  3 in total

1.  Marine Organisms from the Yucatan Peninsula (Mexico) as a Potential Natural Source of Antibacterial Compounds.

Authors:  Dawrin Pech-Puch; Mar Pérez-Povedano; Patricia Gómez; Marta Martínez-Guitián; Cristina Lasarte-Monterrubio; Juan Carlos Vázquez-Ucha; María Lourdes Novoa-Olmedo; Sergio Guillén-Hernández; Harold Villegas-Hernández; Germán Bou; Jaime Rodríguez; Alejandro Beceiro; Carlos Jiménez
Journal:  Mar Drugs       Date:  2020-07-18       Impact factor: 5.118

2.  Experimental and computational studies of an antiplasmodial derivative of allantoin; antimycobacterial essential oil from Cordia batesii WERNHAM (Boraginaceae).

Authors:  Joséphine Ngo Mbing; Dieudonné Emmanuel Pegnyemb; Eric Robert Tiam; Dominique Serge Ngono Bikobo; Ibrahim Mbouombouo Ndassa; Norbert Mbabi Nyemeck Ii; Auguste Abouem A Zintchem; Lawrence Ayong; Patrick Hervé Betote Diboué; Bruno Lenta Ndjakou
Journal:  BMC Chem       Date:  2021-03-05

Review 3.  Marine Pharmacology in 2016-2017: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.

Authors:  Alejandro M S Mayer; Aimee J Guerrero; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Fumiaki Nakamura; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2021-01-21       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.